Evidence map›Paper›PMID 27435599›Full record

ArticleBMC complementary and alternative medicine2016

Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivo.

Yun Mi Lee, Yu-Ri Lee, Chan-Sik Kim, Kyuhyung Jo, Eunjin Sohn, Jin Sook Kim, Junghyun Kim

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Protein Microarrays for Ocular Diseases.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  8. Article
  9. Food science & nutrition · 2020
    Article
  10. EncapsulatedInternational journal of nanomedicine · 2020
    Article
  11. Analgesic Effects ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  12. Enhancement of Endometrial Receptivity byEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. The complete chloroplast genome ofMitochondrial DNA. Part B, Resources · 2018
    Article
  17. Article
  18. Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  19. A Critical Analysis of the AvailableJournal of ophthalmology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yun Mi LeeKorean Medicine Convergence Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon, 34054, South Korea.
Yu-Ri LeeDepartment of Biology, Chungnam National University, Daejeon, 34134, South Korea.
Chan-Sik KimKorean Medicine Convergence Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon, 34054, South Korea.
Kyuhyung JoKorean Medicine Convergence Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon, 34054, South Korea.
Eunjin SohnKorean Medicine Convergence Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon, 34054, South Korea.
Jin Sook KimKorean Medicine Convergence Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon, 34054, South Korea.
Junghyun KimKorean Medicine Convergence Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseongdaero, Yuseong-gu, Daejeon, 34054, South Korea. dvmhyun@kiom.re.kr.
Korea Institute of Oriental Medicine · KRChungnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetinal neovascularization, which is the pathological growth of new blood vessels, is associated with retinopathy of prematurity, neovascular age-related macular degeneration, diabetic retinopathy and retinal vein occlusion. In this study, we evaluated the effect of an extract of Cnidium officinale Makino (COE) and its bioactive compound, butylidenephthalide (BP), on the migration and tube formation of human umbilical vein endothelial cells (HUVECs), and on retinal pathogenic neovascularization in the oxygen-induced retinopathy (OIR) mouse model.

methodThe HUVECs were incubated with COE and BP (0.1-10 μg/ml). The mice were exposed to 75 % oxygen for 5 days starting on the 7(th) postnatal day (P7-P12). Then, the mice were returned to room air and intraperitoneally injected with COE (100 mg/kg) and BP (5 mg/kg) once per day for 5 days (P12-P16). On P17, we measured retinal neovascularization and analyzed the angiogenesis-related proteins expression using protein arrays.

resultsCOE and BP inhibit the HUVECs migration and the tube formation in a dose-dependent manner. In addition, COE significantly decreased retinal neovascularization in the OIR mice. COE reduced the expression levels of AREG, ANG, DLL4, Endostatin, IGFBP-2 and VEGF. Additionally, BP also inhibited the retinal neovascularization and down-regulated the expression of AREG, ANG, DLL4 and VEGF.

conclusionThese results suggest that COE and BP exerts antiangiogenic effects on retinal neovascularization by inhibiting the expression of AREG, ANG, DLL4 and VEGF, indicating that antiangiogenic activities of COE may be in part due to its bioactive compound, BP.

Indexed as

AnimalsCell MovementCells, CulturedCnidiumHumansHuman Umbilical Vein Endothelial CellsMicePhthalic AnhydridesPlant ExtractsRetinal NeovascularizationRibonuclease, PancreaticVascular Endothelial Growth Factor AangiogeninbutylidenephthalidePhthalic AnhydridesPlant ExtractsRibonuclease, PancreaticVascular Endothelial Growth Factor AButylidenephthalideCnidium officinaleOxygen-induced retinopathyRetinal neovascularizationVascular endothelial growth factor

Identifiers

PMID27435599
PMCPMC4949763
OpenAlexW2492533594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.